We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry, White House Silent as Deadline for Alternative Drug Pricing Strategy Passes
Industry, White House Silent as Deadline for Alternative Drug Pricing Strategy Passes
The Trump administration’s Aug. 24 deadline has come and gone for the pharma industry to come up with a drug pricing strategy that would prevent a threatened executive order by President Trump from going into effect — but the White House and big pharma have remained silent.